Page last updated: 2024-08-23

daunorubicin and Cutaneous T-Cell Lymphoma

daunorubicin has been researched along with Cutaneous T-Cell Lymphoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alonso-Llamazares, J; Marchione, R; Ricotti, C; Romanelli, P; Shiman, M	1
Haroske, E; Hohaus, K; Köstler, E; Schönlebe, J; Wollina, U	1

Reviews

1 review(s) available for daunorubicin and Cutaneous T-Cell Lymphoma

Article	Year
CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor). Dermatology online journal, 2008, Nov-15, Volume: 14, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Humans; Immunophenotyping; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Pruritus; Remission Induction; Vincristine	2008

Article

Year

CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).

Dermatology online journal, 2008, Nov-15, Volume: 14, Issue:11

Topics: Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Humans; Immunophenotyping; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Pruritus; Remission Induction; Vincristine

2008

Other Studies

1 other study(ies) available for daunorubicin and Cutaneous T-Cell Lymphoma

Article	Year
Liposomal daunorubicin in tumor stage cutaneous T-cell lymphoma: report of three cases. Journal of cancer research and clinical oncology, 2003, Volume: 129, Issue:1 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administration Schedule; Female; Humans; Liposomes; Lymphoma, T-Cell, Cutaneous; Male; Treatment Outcome	2003